ACERCA DE ESTE PODCAST 🔗
EHA 2015
Duración media del audio:
7 minutes
Inglés
Estados Unidos
29 episodios
desde 6 de agosto de 2015
episodic
ÚLTIMO EPISODIO 🔗
Prof Anton Hagenbeek (Prof Anton Hagenbeek - University Medical Center Utrecht, Utrecht, Netherlands) talks to ecancertv at EHA 2015 about immunoconjugates, the latest targeted treatments in Hodgkin's lymphoma. He also suggests that patients with Hodgkin's disease partake in clinical trials.
ecan…
BUSCAR EPISODIOS ANTERIORES
Buscar episodios anteriores de EHA 2015.
EPISODIOS ANTERIORES 🔗
Dr Hoffmann (Ludwig Maximilian University, Munich, Germany) talks to ecancertv at EHA 2015 about a web-based registry to record all newly-diagnosed chronic myeloid leukaemia (CML) patients in 20 European countries or pre-specified regions covering overall 92.5 million inhabitants.
The researchers …
At a press conference at EHA 2015, Dr Mesa (Mayo Clinic Cancer Center, Scottsdale, USA) presented new data from the Phase 3 PERSIST-1 study which showed that pacritinib is more effective than the best available therapy (BAT) at improving disease symptoms and quality of life (QoL) for patients with …
Dr Olga Guryanova (Memorial Sloan Kettering Cancer Center, New York, USA) presents, at a press conference at EHA 2015, the findings of her work looking at the role of mutant DNMT3A in acute myeloid leukaemia (AML) pathogenesis and chemoresistance.
Dr Meletios Dimopoulos (National and Kapodistrian University of Athens, Athens, Greece) talks to ecancertv at EHA 2015 about the results of ELOQUENT-2, which evaluated elotuzumab in combination with lenalidomide and dexamethasone and is the first Phase III study to demonstrate the benefit of direct…
Dr Ehninger (University Hospital Dresden, Dresden, Germany) presents on the results of a phase II randomised study on the safety and efficacy of sorafenib in leukaemia at a press conference at EHA 2015.
Dr Roberts presents the promising results from an early phase trial combining the anti-bcl-2 drug venetoclax with rituximab to eliminate chronic lymphocytic leukaemia (CLL) at a press conference at EHA 2015.
Prof Anton Hagenbeek (University Medical Center Utrecht, Utrecht, Netherlands) talks to ecancertv at EHA 2015 about the results of Dr Andrew Roberts' early phase Ib trial which looked at combining the anti-bcl-2 drug venetoclax with rituximab to eliminate chronic lymphocytic leukaemia (CLL).
ecanc…
Prof Diehl ( Winner of the Jean Bernard Lifetime Achievement Award) talks to ecancertv at EHA 2015 about his amazing work in the field of Hodgkin's lymphoma and the evolution of research and treatment strategies over time.
ecancer's filming at EHA has been kindly supported by Amgen through the ECM…
Prof Max Topp ( Würzburg University Hospital, Würzburg, Germany) talks to ecancertv at EHA 2015 about his research which showed that acute lymphoblastic leukaemia (ALL) patients with low disease burden had lower responses to blinatumomab. Those with higher disease burden could be candidates for hig…
Descargo de responsabilidad: El podcast y el arte incluidos en esta página son de ecancer, que es propiedad de su propietario y no está afiliado ni respaldado por Listen Notes, Inc.
MOTOR DE BÚSQUEDA DE PODCAST
Puede utilizar nuestro sitio web para buscar podcasts de3,826,122y episodios de196,016,103por personas, lugares o temas.
Invertir en conocimiento ofrece el mejor rendimiento, por eso escucho podcasts.
‐ Benjamin "Llamacorn" Franklin
BUSCAR EPISODIOS ANTERIORES
Buscar episodios anteriores de EHA 2015.
RECLAMAR ESTE PODCAST
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post anuncios clasificados for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
entrevista con podcaster...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
nuestra cuenta oficial de X (antes Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
EDITAR
Gracias por ayudar a mantener actualizada la base de datos de podcasts.
